If you have been NEWLY DIAGNOSED START HERE
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To...
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of...
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with...
La Dra. Estelamari Rodríguez presenta información básica sobre el NSCLC EGFR+ y analiza la importancia de las pruebas de biomarcadores en el cáncer de...
In this video series, Dr. Paul Romesser discusses recent advances in HPV related cancers, including treatment options, vaccination recommendations and...
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated.
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
By Linda Athanasiadou Chemotherapy is one of the most widely used treatments for cancer, but it’s also one of the most daunting. I, Linda Athanasiadou...
Hello, my father has stage 4 NSCLC (exon 21 L858R mutation) with metastasis to his brain. His first treatment was with Tagrisso, which worked...
Thank you for joining us for GRACE's first Blood Cancer ONCTalk
Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder. Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the bile ducts. Help us to bring awareness to these rare cancers during the month of February. Start talking and raise awareness to Gallbladder and Bile Duct Cancer Awareness
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO.
To watch the complete playlist, click here.
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.
La Dra. Estelamari Rodríguez presenta información básica sobre el NSCLC EGFR+ y analiza la importancia de las pruebas de biomarcadores en el cáncer de pulmón y ofrece una descripción general de las opciones de tratamiento para la enfermedad EGFR+.
Para ver la playlist completa, de click aquí.
Hello everyone,
I'm seeking advice as my wife (51) and I navigate a tough treatment decision in her cancer journey. We are incredibly grateful to be nearing 10 years since her diagnosis of stage 4 NSCLC, which had several brain metastases.
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
In this video series, Dr. Paul Romesser discusses recent advances in HPV related cancers, including treatment options, vaccination recommendations and patient perspectives.
To watch the full playlist click here.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock